Pages that link to "Q52563684"
Jump to navigation
Jump to search
The following pages link to Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. (Q52563684):
Displaying 50 items.
- Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders (Q24532028) (← links)
- Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators (Q24681828) (← links)
- Genetic matters: thirty years of progress using mouse models in nicotinic research (Q26853457) (← links)
- Sensory disturbances, inhibitory deficits, and the P50 wave in schizophrenia (Q27026737) (← links)
- Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia (Q28211739) (← links)
- Smoking and mental illness (Q28215784) (← links)
- GTS-21, a mixed nicotinic receptor agonist/antagonist, does not affect the nicotine cue (Q28373869) (← links)
- Selective alpha 7 nicotinic receptor stimulation normalizes chronic cocaine-induced loss of hippocampal sensory inhibition in C3H mice (Q28377115) (← links)
- Differential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in rats (Q28477881) (← links)
- Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways (Q28579410) (← links)
- Fear conditioning and latent inhibition in mice lacking the high affinity subclass of nicotinic acetylcholine receptors in the brain (Q28594253) (← links)
- Nicotine receptor subtype-specific effects on auditory evoked oscillations and potentials (Q28728978) (← links)
- nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives. (Q30362464) (← links)
- Negative affective states and cognitive impairments in nicotine dependence (Q30371220) (← links)
- Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders (Q30372351) (← links)
- Natural genetic variability of the neuronal nicotinic acetylcholine receptor subunit genes in mice: Consequences and confounds (Q30375427) (← links)
- Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits. (Q30381001) (← links)
- Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats (Q30391389) (← links)
- Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking (Q30396291) (← links)
- The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine (Q30404784) (← links)
- Translational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation (Q30407039) (← links)
- Long-term improvements in sensory inhibition with gestational choline supplementation linked to α7 nicotinic receptors through studies in Chrna7 null mutation mice (Q30413798) (← links)
- Nicotine receptors mediating sensorimotor gating and its enhancement by systemic nicotine (Q30417995) (← links)
- Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia (Q30428422) (← links)
- Mouse models for studying genetic influences on factors determining smoking cessation success in humans (Q30432964) (← links)
- Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor (Q30453198) (← links)
- Comparison of the performance of DBA/2 and C57BL/6 mice in transitive inference and foreground and background contextual fear conditioning (Q30455771) (← links)
- Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia (Q30459624) (← links)
- The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice (Q30461965) (← links)
- Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia (Q30473410) (← links)
- The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia. (Q30473421) (← links)
- Cognitive effects of nicotine: genetic moderators (Q30474904) (← links)
- Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism (Q30478352) (← links)
- Perinatal choline deficiency produces abnormal sensory inhibition in Sprague-Dawley rats (Q30485817) (← links)
- Olanzapine improves deficient sensory inhibition in DBA/2 mice (Q30486196) (← links)
- Neurophysiological biomarkers for drug development in schizophrenia (Q30486447) (← links)
- Stimulation of the alpha4beta2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice (Q30487535) (← links)
- The evolution of drug development in schizophrenia: past issues and future opportunities (Q30487850) (← links)
- Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice (Q30488170) (← links)
- An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients (Q30491026) (← links)
- Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice (Q30491257) (← links)
- Smoking, Genetics and Schizophrenia: Evidence for Self Medication (Q30491841) (← links)
- Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men. (Q30493072) (← links)
- Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. (Q30501338) (← links)
- Nicotinic modulation of neuronal networks: from receptors to cognition (Q30993631) (← links)
- Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers (Q33598688) (← links)
- Elementary phenotypes in the neurobiological and genetic study of schizophrenia (Q33679775) (← links)
- Studies on the hippocampal formation: From basic development to clinical applications: Studies on schizophrenia (Q33691327) (← links)
- Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia (Q33709915) (← links)
- Modeling prefrontal cortex delay cells: the role of dopamine in schizophrenia. (Q33768555) (← links)